Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof
A technology of thrombopoietin and stem cell factor, which is applied in the fields of peptide/protein components, peptide preparation methods, recombinant DNA technology, etc., can solve problems such as unsatisfactory effect and short platelet stability time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0059] 1. Use pUC18-SCF as template, use primers 1 and 2 to synthesize SCF gene fragment by PCR method and clone it into pBluscript plasmid vector to obtain pBluscript-3'SCF plasmid, then use pUC18-TPO as template, use primers 3 and 4 The TPO gene fragment was synthesized by PCR method and cloned into pBluscript-3'SCF plasmid vector to obtain pBluscript-TS plasmid. Sequencing proved that the result was completely consistent with the designed sequence. (See attached for the process figure 1 )
[0060] 2. Digest the pBluscript-TS plasmid to obtain the TPO / SCF gene fragment, and insert it into the AcNPV transfer vector pAcSecG2T to obtain the recombinant transfer vector pAcSecG2T-TS. Sf9 was co-transfected with pAcSecG2T-TS and AcNPV DNA, and the recombinant virus AcNPV-rhTPO / SCF without wild-type virus was selected by screening and assay.
[0061] 3. Take the doubling time as 21 hours, live cells account for 90%, and the density is 6×10 5 Cells / mL single-layer Sf9 cells were...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com